{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:40:22Z","timestamp":1765546822612,"version":"3.41.2"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T00:00:00Z","timestamp":1638921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Hepatoblastoma (HB) is a rare embryonal tumor, although it is the most common pediatric liver cancer. The aim of this study was to provide an accurate cytogenomic profile of this type of cancer, for which information in cancer databases is lacking. We performed an extensive literature review of cytogenetic studies on HBs disclosing that the most frequent copy number alterations (CNAs) are gains of 1q, 2\/2q, 8\/8q, and 20; and losses at 1p and 4q. Furthermore, the CNA profile of a Brazilian cohort of 26 HBs was obtained by array-CGH; the most recurrent CNAs were the same as shown in the literature review. Importantly, HBs from female patients, high-risk stratification tumors, tumors who developed in older patients (&amp;gt; 3 years at diagnosis) or from patients with metastasis and\/or deceased carried a higher diversity of chromosomal alterations, specifically chromosomal losses at 1p, 4, 11q and 18q. In addition, we distinguished three major CNA profiles: no detectable CNA, few CNAs and tumors with complex genomes. Tumors with simpler genomes exhibited a significant association with the epithelial fetal subtype of HBs; in contrast, the complex genome group included three cases with epithelial embryonal histology, as well as the only HB with HCC features. A significant association of complex HB genomes was observed with older patients who developed high-risk tumors, metastasis, and deceased. Moreover, two patients with HBs exhibiting complex genomes were born with congenital anomalies. Together, these findings suggest that a high load of CNAs, mainly chromosomal losses, particularly losses at 1p and 18, increases the tendency to HB aggressiveness. Additionally, we identified six hot-spot chromosome regions most frequently affected in the entire group: 1q31.3q42.3, 2q23.3q37.3, and 20p13p11.1 gains, besides a 5,3 Mb amplification at 2q24.2q24.3, and losses at 1p36.33p35.1, 4p14 and 4q21.22q25. An <jats:italic>in-silico<\/jats:italic> analysis using the genes mapped to these six regions revealed several enriched biological pathways such as ERK Signaling, MicroRNAs in Cancer, and the PI3K-Akt Signaling, in addition to the WNT Signaling pathway; further investigation is required to evaluate if disturbances of these pathways can contribute to HB tumorigenesis. The analyzed gene set was found to be associated with neoplasms, abnormalities of metabolism\/homeostasis and liver morphology, as well as abnormal embryonic development and cytokine secretion. In conclusion, we have provided a comprehensive characterization of the spectrum of chromosomal alterations reported in HBs and identified specific genomic regions recurrently altered in a Brazilian HB group, pointing to new biological pathways, and relevant clinical associations.<\/jats:p>","DOI":"10.3389\/fonc.2021.741526","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T05:04:32Z","timestamp":1638939872000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Copy Number Alterations in Hepatoblastoma: Literature Review and a Brazilian Cohort Analysis Highlight New Biological Pathways"],"prefix":"10.3389","volume":"11","author":[{"given":"Juliana Sobral","family":"Barros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talita Ferreira Marques","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia Souza","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Prates","family":"Rivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Cypriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia Regina Caminada","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estela Maria","family":"Novak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Odone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilian Maria","family":"Cristofani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirce Maria","family":"Carraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabela","family":"Werneck da Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cec\u00edlia Maria Lima","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela M.","family":"Vianna-Morgante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Cristina Victorino","family":"Krepischi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40880-019-0411-7","article-title":"Incidence Trends and Survival Prediction of Hepatoblastoma in Children: A Population-Based Study","volume":"39","author":"Feng","year":"2019","journal-title":"Cancer Commun"},{"key":"B2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MOP.0000000000000046","article-title":"Hepatoblastoma State of the Art: Pathology, Genetics, Risk Stratification, and Chemotherapy","volume":"26","author":"Czauderna","year":"2014","journal-title":"Curr Opin Pediatr"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41241-017-0021-0","article-title":"The Genetic and Epigenetic Landscapes of Hepatoblastomas","volume":"37","author":"Aguiar","year":"2017","journal-title":"Appl Cancer Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajmg.a.36638","article-title":"Congenital Abnormalities and Hepatoblastoma: A Report from the Children\u2019s Oncology Group (COG) and the Utah Population Database (UPDB)","volume":"23","author":"Venkatramani","year":"2014","journal-title":"Am J Med Genet Part A"},{"key":"B5","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1053\/j.semdp.2016.12.015","article-title":"Hepatoblastoma","volume":"34","author":"Sharma","year":"2017","journal-title":"Semin Diagn Pathol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.025","article-title":"Epigenetic Footprint Enables Molecular Risk Stratification of Hepatoblastoma With Clinical Implications","volume":"73","author":"Carrillo-Reixach","year":"2020","journal-title":"J Hepatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604754","article-title":"Loss of Imprinting of IGF2 Correlates With Hypermethylation of the H19 Differentially Methylated Region in Hepatoblastoma","volume":"99","author":"Honda","year":"2008","journal-title":"Br J Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2007.00710.x","article-title":"Whole-Genome Profiling of Chromosomal Aberrations in Hepatoblastoma Using High-Density Single-Nucleotide Polymorphism Genotyping Microarrays","volume":"99","author":"Suzuki","year":"2008","journal-title":"Cancer Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/gcc.20770","article-title":"Genome-Wide Analysis of Allelic Imbalances Reveals 4q Deletions as a Poor Prognostic Factor and MDM4 Amplification at 1q32.1 in Hepatoblastoma","volume":"49","author":"Arai","year":"2010","journal-title":"Genes Chromosom Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24213","article-title":"Genetics and Epigenetics of Hepatoblastoma","volume":"59","author":"Tomlinson","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2264(199708)19:4<291::AID-GCC13>3.0.CO;2-J","article-title":"The First Recurring Chromosome Translocation in Hepatoblastoma: Der(4)T(1;4)(Q12;Q34)","volume":"19","author":"Schneider","year":"1997","journal-title":"Genes Chromosom Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2217\/fon.14.149","article-title":"Upregulated Genes at 2q24 Gains as Candidate Oncogenes in Hepatoblastomas","volume":"10","author":"Rodrigues","year":"2014","journal-title":"Futur Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejca.2015.09.023","article-title":"The Children\u2019s Hepatic Tumors International Collaboration (CHIC): Novel Global Rare Tumor Database Yields New Prognostic Factors in Hepatoblastoma and Becomes a Research Model","volume":"52","author":"Czauderna","year":"2016","journal-title":"Eur J Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30598-8","article-title":"Risk-Stratified Staging in Paediatric Hepatoblastoma: A Unified Analysis From the Children\u2019s Hepatic Tumors International Collaboration","volume":"18","author":"Meyers","year":"2017","journal-title":"Lancet Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2020.00556","article-title":"Insights Into the Somatic Mutation Burden of Hepatoblastomas From Brazilian Patients","volume":"10","author":"Aguiar","year":"2020","journal-title":"Front Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers10010004","article-title":"The Role of Chromosomal Instability in Cancer and Therapeutic Responses","volume":"10","author":"Vargas-Rond\u00f3n","year":"2018","journal-title":"Cancers (Basel)"},{"key":"B17","first-page":"1","article-title":"Establishment of a Cell Line and Its Clonal Sublines From a Patient With Hepatoblastoma","volume":"67","author":"Doi","year":"1976","journal-title":"Gann Japan J Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.18926\/AMO\/30534","article-title":"Chromosome Analysis in a Human Hepatoblastoma Cell Line Producing \u03b1-Fetoprotein","volume":"34","author":"Miyamoto","year":"1980","journal-title":"Acta Med Okayama"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2741\/e459","article-title":"Cytogenetics of Hepatoblastoma","volume":"4","author":"Tomlinson","year":"2012","journal-title":"Front Biosci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20227","article-title":"Cytogenetic Evaluation of a Large Series of Hepatoblastomas: Numerical Abnormalities With Recurring Aberrations Involving 1q12-Q21","volume":"44","author":"Tomlinson","year":"2005","journal-title":"Genes Chromosom Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28888","article-title":"Genomic Analysis of Hepatoblastoma Identifies Distinct Molecular and Prognostic Subgroups","volume":"65","author":"Sumazin","year":"2017","journal-title":"Hepatology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-014-0065-9","article-title":"The Genetic and Epigenetic Alterations in Human Hepatocellular Carcinoma: A Recent Update","volume":"5","author":"Liu","year":"2014","journal-title":"Protein Cell"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-3014","article-title":"CAMTA1, a 1p36 Tumor Suppressor Candidate, Inhibits Growth and Activates Differentiation Programs in Neuroblastoma Cells","volume":"71","author":"Henrich","year":"2011","journal-title":"Cancer Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevOncog.2015013800","article-title":"Pediatric Rhabdomyosarcoma","volume":"20","author":"Shern","year":"2018","journal-title":"Crit Rev Oncog"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-2230","article-title":"1p36 Tumor Suppression - A Matter of Dosage","volume":"72","author":"Henrich","year":"2012","journal-title":"Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41698-020-0125-y","article-title":"Integrated Multiomics Analysis of Hepatoblastoma Unravels Its Heterogeneity and Provides Novel Druggable Targets","volume":"4","author":"Sekiguchi","year":"2020","journal-title":"NPJ Precis Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1515\/bmc-2013-0026","article-title":"Gene Amplification: Mechanisms and Involvement in Cancer","volume":"4","author":"Matsui","year":"2013","journal-title":"Biomol Concepts"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1390","article-title":"Comparative Genomic Hybridization Reveals Population-Based Genetic Alterations in Hepatoblastomas","volume":"83","author":"Gray","year":"2000","journal-title":"Br J Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/(SICI)1098-2264(200002)27:2<196::AID-GCC12>3.0.CO;2-D","article-title":"Comparative Genomic Hybridization Analysis of Hepatoblastomas","volume":"27","author":"Hu","year":"2000","journal-title":"Genes Chromosom Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2009.06.039","article-title":"Hepatoblastoma in a Patient With Sotos Syndrome","volume":"155","author":"Kato","year":"2009","journal-title":"J Pediatr"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2001.tb01172.x","article-title":"Frequent Increase of DNA Copy Number in the 2q24 Chromosomal Region and Its Association With a Poor Clinical Outcome in Hepatoblastoma: Cytogenetic and Comparative Genomic Hybridization Analysis","volume":"92","author":"Kumon","year":"2001","journal-title":"Japan J Cancer Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64567-1","article-title":"Characterization of Genomic Alterations in Hepatoblastomas: A Role for Gains on Chromosomes 8q and 20 as Predictors of Poor Outcome","volume":"157","author":"Weber","year":"2000","journal-title":"Am J Pathol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1134\/S1607672916050033","article-title":"Expression of the FAP Gene in Non-Fibroblast Human Cell Lines. Development of Cancer-Associated Fibroblast Models","volume":"470","author":"Tyulkina","year":"2016","journal-title":"Dokl Biochem Biophys"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.02.015","article-title":"CD26\/DPP4 - a Potential Biomarker and Target for Cancer Therapy","volume":"198","author":"Enz","year":"2019","journal-title":"Pharmacol Ther"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0181246","article-title":"Pediatric Cancer Risk in Association With Birth Defects: A Systematic Review","volume":"12","author":"Johnson","year":"2017","journal-title":"PloS One"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.08.009","article-title":"The Genomic Landscape of Hepatoblastoma and Their Progenies With HCC-Like Features","volume":"61","author":"Eichenm\u00fcller","year":"2014","journal-title":"J Hepatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14208","article-title":"DNA Methylation Landscape of Hepatoblastomas Reveals Arrest at Early Stages of Liver Differentiation and Cancer-Related Alterations","volume":"8","author":"Maschietto","year":"2017","journal-title":"Oncotarget"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fgene.2019.00553","article-title":"TET Upregulation Leads to 5-Hydroxymethylation Enrichment in Hepatoblastoma","volume":"10","author":"Rivas","year":"2019","journal-title":"Front Genet"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1010428320977124","article-title":"Hepatoblastomas Exhibit Marked NNMT Downregulation Driven by Promoter DNA Hypermethylation","volume":"42","author":"Rivas","year":"2020","journal-title":"Tumor Biol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2021.101684","article-title":"DNA Methylation as a Key Epigenetic Player for Hepatoblastoma Characterization","volume":"45","author":"Rivas","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/hep.29672","article-title":"New Insights Into Diagnosis and Therapeutic Options for Proliferative Hepatoblastoma","volume":"68","author":"Hooks","year":"2018","journal-title":"Hepatology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201707814","article-title":"Mutant CTNNB 1 and Histological Heterogeneity Define Metabolic Subtypes of Hepatoblastoma","volume":"9","author":"Crippa","year":"2017","journal-title":"EMBO Mol Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1242\/dev.143818","article-title":"Outstanding Questions in Developmental ERK Signaling","volume":"145","author":"Patel","year":"2018","journal-title":"Dev"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20051194","article-title":"Nuclear Erk: Mechanism of Translocation, Substrates, and Role in Cancer","volume":"20","author":"Maik-Rachline","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1146\/annurev-med-062913-051343","article-title":"The PI3K\/AKT Pathway as a Target for Cancer Treatment","volume":"67","author":"Mayer","year":"2016","journal-title":"Annu Rev Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.fct.2016.03.013","article-title":"Involvement of PI3K\/Akt, ERK and P38 Signaling Pathways in Emodin-Mediated Extrinsic and Intrinsic Human Hepatoblastoma Cell Apoptosis","volume":"92","author":"Cui","year":"2016","journal-title":"Food Chem Toxicol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pbc.27745","article-title":"Characterization of Pediatric Hepatocellular Carcinoma Reveals Genomic Heterogeneity and Diverse Signaling Pathway Activation","volume":"66","author":"Haines","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"B48","doi-asserted-by":"publisher","first-page":"89","DOI":"10.20892\/j.issn.2095-3941.2018.0077","article-title":"Periostin Mediates Epithelial-Mesenchymal Transition Through the MAPK\/ERK Pathway in Hepatoblastoma","volume":"16","author":"Chen","year":"2019","journal-title":"Cancer Biol Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-019-1943-0","article-title":"DPEP1 Is a Direct Target of miR-193a-5p and Promotes Hepatoblastoma Progression by PI3K\/Akt\/mTOR Pathway","volume":"10","author":"Cui","year":"2019","journal-title":"Cell Death Dis"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-12-193","article-title":"Roles of CXCL5 on Migration and Invasion of Liver Cancer Cells","volume":"12","author":"Xu","year":"2014","journal-title":"J Transl Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20071493","article-title":"Chemokines and Cancer: Migration, Intracellular Signalling and Intercellular Communication in the Microenvironment","volume":"409","author":"O\u2019Hayre","year":"2008","journal-title":"Biochem J"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i10.1390","article-title":"Chemokines and Their Receptors Play Important Roles in the Development of Hepatocellular Carcinoma","volume":"7","author":"Liang","year":"2015","journal-title":"World J Hepatol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.6396","article-title":"Role of C-X-C Chemokine Ligand 12\/C-X-C Chemokine Receptor 4 in the Progression of Hepatocellular Carcinoma (Review)","volume":"14","author":"Jeng","year":"2017","journal-title":"Oncol Lett"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.10011","article-title":"Identification of Targetable Molecular Alterations in the NCI-COG Pediatric MATCH Trial","volume":"37","author":"Parsons","year":"2019","journal-title":"J Clin Oncol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-019-03047-2","article-title":"Co-Targeting PI3K\/Akt and MAPK\/ERK Pathways Leads to an Enhanced Antitumor Effect on Human Hypopharyngeal Squamous Cell Carcinoma","volume":"145","author":"Peng","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-0359","article-title":"OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer","volume":"76","author":"Svoronos","year":"2016","journal-title":"Cancer Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers11030409","article-title":"The Role of microRNAs in Hepatoblastoma Tumors","volume":"11","author":"Crist\u00f3bal","year":"2019","journal-title":"Cancers (Basel)"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.741526\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T05:04:41Z","timestamp":1638939881000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.741526\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,8]]},"references-count":57,"alternative-id":["10.3389\/fonc.2021.741526"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.741526","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2021,12,8]]},"article-number":"741526"}}